Baillie Gifford & Co. lowered its position in shares of 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 1.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 8,340,898 shares of the company’s stock after selling 163,349 shares during the quarter. Baillie Gifford & Co. […]